Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 4, 2018BMC CancerOpen Access

Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

YYYalian YuFujian Medical UniversityHWHongbo WangWeifang Medical UniversityAYAihui YanFirst Hospital of China Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yu et al. (2018) studied this question.

synapsesocial.com/papers/6a79070ec72ca19efaf9abc9https://doi.org/10.1186/s12885-018-4230-z
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inflammation‐induced activation of the indoleamine 2,3‐dioxygenase pathway: Relevance to cancer‐related fatigue2015 · 93 citations
  2. 2Neutrophil‐to‐lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma2015 · 139 citations
  3. 3Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer2015 · 43 citations
  4. 4Simple prognostic score for metastatic castration‐resistant prostate cancer with incorporation of neutrophil‐to‐lymphocyte ratio2014 · 147 citations